ARTICLE | Company News
Celera, Nanogen deal
October 27, 2008 7:00 AM UTC
The partners added in vitro cardiovascular and cancer diagnostics to Celera's rights under a 2004 license to Nanogen's Minor Groove Binder (MGB) and Eclipse Dark Quencher technologies. The original de...